In vivo activation of NKT cells by alpha galactosylceramide...

Diabetes Research and Clinical Practice 2000 Vol. 50; Iss. supp-S1

In vivo activation of NKT cells by alpha galactosylceramide prevents autoimmune type I diabetes

Shayan Sharif, Guillermo A Arreaza, Terry L Delovitch
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Year:
2000
Language:
english
DOI:
10.1016/s0168-8227(00)82019-7
File:
PDF, 147 KB
english, 2000
Conversion to is in progress
Conversion to is failed